成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

4-(4-methylpiperazin-1-yl)-2-nitrobenzoic acid

4-(4-methylpiperazin-1-yl)-2-nitrobenzoic acid Struktur
942271-67-2
CAS-Nr.
942271-67-2
Englisch Name:
4-(4-methylpiperazin-1-yl)-2-nitrobenzoic acid
Synonyma:
4-(4-methyl-1-piperazinyl)-2-nitrobenzoic acid;4-(4-methylpiperazin-1-yl)-2-nitrobenzoic acid;Benzoic acid, 4-(4-methyl-1-piperazinyl)-2-nitro-
CBNumber:
CB82748320
Summenformel:
C12H15N3O4
Molgewicht:
265.27
MOL-Datei:
942271-67-2.mol

4-(4-methylpiperazin-1-yl)-2-nitrobenzoic acid Eigenschaften

Sicherheit

4-(4-methylpiperazin-1-yl)-2-nitrobenzoic acid Chemische Eigenschaften,Einsatz,Produktion Methoden

4-(4-methylpiperazin-1-yl)-2-nitrobenzoic acid Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


4-(4-methylpiperazin-1-yl)-2-nitrobenzoic acid Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 10)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
SHANGHAI T&W PHARMACEUTICAL CO., LTD.
+86-021-61551413 +8618813727289
contact@trustwe.com China 5738 58
Finetech Industry Limited
+86-27-87465837 +8618971612321
info@finetechnology-ind.com China 9639 58
Finetech Industry Limited 027-87465837 19945049750
sales@finetechnology-ind.com China 9648 58
Shanghai Jinsheng Pharmaceutical Co., Ltd. 1365-13651960330 13651960330
xiangfeixia@jspharmatech.com China 319 58
Nanjing crow LuNing pharmaceutical technology co., LTD 13382066392
CHINA 4877 58
Suzhou Rovathin Foreign Trade Co.,Ltd 0512-65816829 18662214788
info@rovathin.com.cn China 9673 58
Beijing xinyanhui pharmaceutical research and development co., LTD 13969155946
1461866103@qq.com China 16111 58
Pharmalego 13472578225 18321033991
marketing@pharmalego.com China 2964 58
Taizhou Zhongzhi Biotechnology Co., Ltd 13012344321
3995296515@qq.com China 7996 58

  • 4-(4-methylpiperazin-1-yl)-2-nitrobenzoic acid
  • 4-(4-methyl-1-piperazinyl)-2-nitrobenzoic acid
  • Benzoic acid, 4-(4-methyl-1-piperazinyl)-2-nitro-
  • 942271-67-2
Copyright 2019 ? ChemicalBook. All rights reserved